Brian Cogley - 10 Jan 2024 Form 3 Insider Report for Coeptis Therapeutics Holdings, Inc. (COEP)

Role
Chief Financial Officer
Signature
/s/ Brian Cogley
Issuer symbol
COEP
Transactions as of
10 Jan 2024
Net transactions value
$0
Form type
3
Filing time
17 Jan 2024, 16:01:21 UTC
Next filing
06 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding COEP Common Stock 30,000 10 Jan 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 25,000 shares of common stock that are issuable upon exercise of options that are or will become exercisable in the next 60 days.